The short interest data are out for September 15, the most recent settlement date. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big potential upside and big potential downside.
As we have said before, FDA rulings can make or break the biotech stocks, and short sellers and mega-bulls often go to war against each other in these companies. After all, if a single failed clinical trial can mean disaster for a stock, then some short sellers can argue for a stock implosion down the road.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The September 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Alexion Pharmaceuticals Inc.’s (NASDAQ: ALXN) short interest increased to 5.08 million shares from the previous 4.84 million. Shares recently traded at $112.02, in a 52-week range of $72.67 to $121.50.
Amgen Inc. (NASDAQ: AMGN) saw its short interest increase to 6.77 million shares from the previous level of 6.20 million. Shares were trading at $240.32, in a 52-week range of $177.05 to $264.97.
Short interest in Biogen Inc. (NASDAQ: BIIB) rose to 3.69 million shares from 3.31 million in the prior period. The stock traded at $270.04, within a 52-week range of $219.70 to $374.99.
Gilead Sciences Inc. (NASDAQ: GILD) saw its short interest rise to 17.95 million shares from 16.17 million in the previous period. Shares were trading at $62.25, in a 52-week range of $60.89 to $85.97.
The number of Moderna Inc. (NASDAQ: MRNA) shares short grew from 28.02 million to 28.22 million in the period. The share price was $67.77 Friday morning and has ranged from $95.21 to $13.53 in the past year.
Regeneron Pharmaceuticals Inc.’s (NASDAQ: REGN) short interest increased slightly to 1.60 million from the previous 1.59 million. The stock traded at $557.46 a share, in a 52-week range of $271.37 to $664.64.
And the number of Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) shares short decreased to 3.04 million. The previous reading was 3.35 million. The shares traded at $263.13 apiece, in a 52-week range of $165.23 to $306.08.
24/7 Wall St.Sponsored: Attention Savvy Investors: Speak to 3 Financial Experts – FREE
Ever wanted an extra set of eyes on an investment you’re considering? Now you can speak with up to 3 financial experts in your area for FREE. By simply
clicking here you can begin to match with financial professionals who can help guide you through the financial decisions you’re making. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
